Qi-Bing Xie Selected Research

Neurogenic Diabetes Insipidus (Central Diabetes Insipidus)

10/2020

Central diabetes insipidus unveiled by glucocorticoid therapy in a patient with an empty sella: A case report and literature review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qi-Bing Xie Research Topics

Disease

4	Inflammation (Inflammations) 01/2017 - 11/2012
4	Rheumatoid Arthritis 01/2014 - 01/2009
3	Dermatomyositis (Dermatopolymyositis) 03/2018 - 05/2011
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2016 - 05/2011
2	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2018 - 09/2013
2	Polymyositis 01/2017 - 09/2011
2	Connective Tissue Diseases (Connective Tissue Disease) 09/2013 - 05/2011
2	Myositis (Idiopathic Inflammatory Myopathies) 09/2013 - 09/2013
2	Arthritis (Polyarthritis) 11/2012 - 05/2011
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 10/2020
1	Hypopituitarism (Sheehan's Syndrome) 10/2020
1	Ulcer 03/2019
1	Thyroiditis 03/2018
1	Neoplasms (Cancer) 03/2018
1	Mediastinal Emphysema (Pneumomediastinum) 03/2018
1	Amyopathic dermatomyositis 03/2018
1	Tuberous Sclerosis (Bourneville's Disease) 01/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Myalgia 01/2017
1	Chronic Disease (Chronic Diseases) 01/2017
1	Crohn Disease (Crohn's Disease) 12/2015
1	Knee Osteoarthritis 01/2015
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 01/2014
1	Infections 09/2013
1	Pneumonia (Pneumonitis) 09/2013
1	Experimental Arthritis 11/2012
1	Heart Failure 09/2011
1	Sclerosis 05/2011
1	Mixed Connective Tissue Disease (MCTD) 05/2011
1	Systemic Scleroderma (Systemic Sclerosis) 05/2011
1	Tuberculosis (Tuberculoses) 01/2009
1	Pulmonary Tuberculosis 01/2009

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 03/2018 - 01/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2017 - 01/2017
2	Sirolimus (Rapamycin)FDA Link 01/2017 - 01/2017
2	EnzymesIBA 01/2017 - 05/2011
2	Phosphotransferases (Kinase)IBA 12/2016 - 09/2013
1	GlucocorticoidsIBA 10/2020
1	Hormones (Hormone)IBA 10/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2018
1	AlbuminsIBA 03/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2018
1	AntigensIBA 03/2018
1	LipidsIBA 01/2017
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2017
1	palmitoleic acidIBA 01/2017
1	Interleukin-23 (Interleukin 23)IBA 12/2015
1	Diclofenac (SR 38)FDA LinkGeneric 01/2015
1	Leflunomide (Arava)FDA LinkGeneric 01/2014
1	Interleukin-6 (Interleukin 6)IBA 09/2013
1	Jo-1 antibodyIBA 09/2013
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 09/2013
1	AminoglycosidesIBA 09/2013
1	Transaminases (Aminotransferases)IBA 09/2013
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 09/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2013
1	AntibodiesIBA 09/2013
1	Antinuclear AntibodiesIBA 09/2013
1	C-Reactive ProteinIBA 09/2013
1	Cephalosporins (Cephalosporin Antibiotics)IBA 09/2013
1	CreatineIBA 09/2013
1	Ferritins (Ferritin)IBA 09/2013
1	FluoroquinolonesIBA 09/2013
1	artenimol (dihydroartemisinin)IBA 11/2012
1	CollagenIBA 11/2012
1	Creatine Kinase (Creatine Phosphokinase)IBA 09/2011
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2011
1	Indicators and Reagents (Reagents)IBA 05/2011
1	ImmunosorbentsIBA 05/2011
1	Anti-Citrullinated Protein AntibodiesIBA 05/2011
1	cyclic citrullinated peptideIBA 05/2011
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2009
1	Methotrexate (Mexate)FDA LinkGeneric 01/2009

Therapy/Procedure

6	Therapeutics 10/2020 - 01/2009